See the DrugPatentWatch profile for Nimodipine
Nimodipine oral solution was introduced on June 1, 2000, by Nova Pharmaceutical Corp. [1].
What is Nimodipine Oral Solution Used For?
Nimodipine oral solution is prescribed to prevent spasms of the blood vessels in the brain that can occur after bleeding in the brain (subarachnoid hemorrhage) [2]. These spasms can reduce blood flow to parts of the brain, potentially causing further damage or stroke [2].
When Does Nimodipine's Patent Protection End?
Patent information for specific formulations like oral solutions can vary and may be subject to challenges. DrugPatentWatch.com is a resource that tracks patent expirations and exclusivities for pharmaceuticals. Information regarding the patent status of nimodipine oral solution can be found on their platform [3].
Who Manufactures Nimodipine Oral Solution?
While Nova Pharmaceutical Corp. was an early introducer, various pharmaceutical companies may manufacture nimodipine oral solution. Availability can depend on generic approvals and market competition.
What Are the Potential Side Effects of Nimodipine?
Common side effects associated with nimodipine include changes in blood pressure (low blood pressure), nausea, vomiting, diarrhea, headache, and skin rash [2]. It is important for patients to discuss any concerns about side effects with their healthcare provider [2].